SG10201807682PA - Methods of Treating or Preventing Respiratory Conditions - Google Patents

Methods of Treating or Preventing Respiratory Conditions

Info

Publication number
SG10201807682PA
SG10201807682PA SG10201807682PA SG10201807682PA SG10201807682PA SG 10201807682P A SG10201807682P A SG 10201807682PA SG 10201807682P A SG10201807682P A SG 10201807682PA SG 10201807682P A SG10201807682P A SG 10201807682PA SG 10201807682P A SG10201807682P A SG 10201807682PA
Authority
SG
Singapore
Prior art keywords
treating
respiratory
methods
subject
preventing respiratory
Prior art date
Application number
SG10201807682PA
Other languages
English (en)
Inventor
Ravi Krishnan
Peter Ghosh
Silviu Itescu
Original Assignee
Mesoblast Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mesoblast Inc filed Critical Mesoblast Inc
Publication of SG10201807682PA publication Critical patent/SG10201807682PA/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0652Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662Stem cells
    • C12N5/0663Bone marrow mesenchymal stem cells (BM-MSC)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Rheumatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
SG10201807682PA 2012-12-12 2013-12-12 Methods of Treating or Preventing Respiratory Conditions SG10201807682PA (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201261736352P 2012-12-12 2012-12-12

Publications (1)

Publication Number Publication Date
SG10201807682PA true SG10201807682PA (en) 2018-10-30

Family

ID=50933587

Family Applications (2)

Application Number Title Priority Date Filing Date
SG11201504352TA SG11201504352TA (en) 2012-12-12 2013-12-12 Methods of treating or preventing respiratory conditions
SG10201807682PA SG10201807682PA (en) 2012-12-12 2013-12-12 Methods of Treating or Preventing Respiratory Conditions

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SG11201504352TA SG11201504352TA (en) 2012-12-12 2013-12-12 Methods of treating or preventing respiratory conditions

Country Status (12)

Country Link
US (3) US10028979B2 (ja)
EP (1) EP2931373B1 (ja)
JP (5) JP6313327B2 (ja)
KR (1) KR101748712B1 (ja)
CN (2) CN105377274A (ja)
AU (4) AU2013360026B2 (ja)
CA (1) CA2893951C (ja)
ES (1) ES2759281T3 (ja)
HK (1) HK1210077A1 (ja)
IL (1) IL239309A0 (ja)
SG (2) SG11201504352TA (ja)
WO (1) WO2014089625A1 (ja)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105377274A (zh) 2012-12-12 2016-03-02 麦瑟布莱斯特公司 治疗或预防呼吸病症的方法
WO2016049156A1 (en) * 2014-09-23 2016-03-31 Case Western Reserve University Compositions and methods for treating lung remodeling diseases
US11471493B2 (en) * 2017-09-15 2022-10-18 Cynata Therapeutics Limited Method for treating allergic airways disease (AAD)/asthma
CN110680833A (zh) * 2018-06-20 2020-01-14 中国科学院遗传与发育生物学研究所 一种结合肺灌洗治疗尘肺病的套药
EP4098267A4 (en) * 2020-01-30 2024-03-06 Japan Chem Res MEDICINAL COMPOSITION COMPRISING CELLS DERIVED FROM DENTAL PULP

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003901668A0 (en) 2003-03-28 2003-05-01 Medvet Science Pty. Ltd. Non-haemopoietic precursor cells
ES2287447T3 (es) * 2002-02-19 2007-12-16 Medipost, Co., Ltd. Metodos de aislamiento y expansion del cultivo de celulas troncales/madre mesenquimatosas a partir de sangre del cordon umbilical, y metodo de diferenciacion de celulas troncales/madre mesenquimatosas derivadas de sangre del cordon umbilical en diversos tejidos mesenquimatosos.
US20080095749A1 (en) * 2004-03-22 2008-04-24 Sudeepta Aggarwal Mesenchymal stem cells and uses therefor
CN101506355B (zh) * 2004-09-24 2012-06-27 成血管细胞系统公司 多能扩增间充质前体细胞子代(memp)及其应用
ES2654428T3 (es) * 2005-04-12 2018-02-13 Mesoblast, Inc. Aislamiento de células multipotenciales adultas por fosfatasa alcalina no específica de tejido
US20120269774A1 (en) 2006-09-21 2012-10-25 Medistem Laboratories, Inc Allogeneic stem cell transplants in non-conditioned recipients
US20090053182A1 (en) 2007-05-25 2009-02-26 Medistem Laboratories, Inc. Endometrial stem cells and methods of making and using same
KR101688449B1 (ko) * 2007-08-06 2016-12-21 메소블라스트, 아이엔씨. 생체 내에서 결합 조직을 생성, 복구 및/또는 유지하는 방법
US20100247577A1 (en) * 2007-10-17 2010-09-30 Txcell Tr1 cells, mesenchymal stem cells and uses thereof
CN102144028B (zh) * 2008-09-03 2017-12-26 中胚有限公司 造血前体的扩增
CN103079578B (zh) * 2010-07-02 2017-02-15 迈索布拉斯特股份有限公司 治疗移植物抗宿主疾病的方法
US9901600B2 (en) * 2011-03-11 2018-02-27 Children's Medical Center Corporation Methods and compositions relating to mesenchymal stem cell exosomes
US10206951B2 (en) * 2011-06-03 2019-02-19 Mesoblast, Inc. Methods of treating multiple sclerosis using STRO-1+ and TNAP+ multipotential cells
CN105377274A (zh) 2012-12-12 2016-03-02 麦瑟布莱斯特公司 治疗或预防呼吸病症的方法

Also Published As

Publication number Publication date
US20150306146A1 (en) 2015-10-29
SG11201504352TA (en) 2015-07-30
IL239309A0 (en) 2015-07-30
CA2893951A1 (en) 2014-06-19
AU2018226514B2 (en) 2020-01-02
JP2020097618A (ja) 2020-06-25
CN105377274A (zh) 2016-03-02
WO2014089625A1 (en) 2014-06-19
ES2759281T3 (es) 2020-05-08
KR101748712B1 (ko) 2017-06-19
AU2013360026A1 (en) 2015-07-02
US10028979B2 (en) 2018-07-24
AU2022209219A1 (en) 2022-08-18
JP6313327B2 (ja) 2018-04-18
EP2931373B1 (en) 2019-08-21
HK1210077A1 (en) 2016-04-15
EP2931373A1 (en) 2015-10-21
EP2931373A4 (en) 2016-05-04
AU2013360026B2 (en) 2018-06-21
CA2893951C (en) 2022-05-03
JP7420844B2 (ja) 2024-01-23
CN115919901A (zh) 2023-04-07
US20200289578A1 (en) 2020-09-17
US20190046575A1 (en) 2019-02-14
JP2022065132A (ja) 2022-04-26
JP2024041904A (ja) 2024-03-27
US10688134B2 (en) 2020-06-23
KR20150090237A (ko) 2015-08-05
JP2018118987A (ja) 2018-08-02
AU2020202022A1 (en) 2020-04-09
JP6665218B2 (ja) 2020-03-13
AU2018226514A1 (en) 2018-09-27
JP2016502980A (ja) 2016-02-01

Similar Documents

Publication Publication Date Title
SG10201807682PA (en) Methods of Treating or Preventing Respiratory Conditions
BR112013011827A2 (pt) ''respirador com peça facial filtrante que tem uma vedação facial moldada com sobreposição''
EP2560681A4 (en) USE OF TAU FOR MONITORING IMMUNOTHERAPY
HRP20190109T1 (hr) Ljudska antitijela na gfr 3 i načini za njihovu primjenu
BR112013011108A2 (pt) ''respirador de peça facial filtrante que tem uma estrutura de suporte moldada por injeção á estrutura filtrante''
HK1180320A1 (en) Pyrimidine derivatives and their use in the treatment of respiratory diseases such as copd copd
NZ778131A (en) Low eructation composition and methods for treating and/or preventing cardiovascular disease in a subject with fish allergy/hypersensitivity
IL248880B (en) Preparations containing r-g-cysteic acid peptides and their uses for the treatment of eye diseases
EP2528934A4 (en) AROMATIC-CATIONIC PEPTIDES AND USES THEREOF
WO2012093258A3 (en) Irf5- related treatment and screening
EA019744B9 (ru) Изотиазолилоксифениламидины и их применение для борьбы с фитопатогенными грибами и семенной материал, обработанный изотиазолилоксифениламидинами
MX2013013752A (es) Pirfenidona y tratamiento anti-fibrotico en pacientes seleccionados.
MX2013000674A (es) Metodo para identificar a un paciente con incrementada probabilidad de responder a una terapia anticancer.
IL234101B (en) Preparations containing acamprosate and baclofen for use in the treatment of Parkinson's disease
TN2013000427A1 (en) Modified acid alpha glucosidase with accelerated processing
MX348708B (es) Métodos para mejorar el desarrollo del cerebro y la función cognoscitiva al usar beta-hidroxi-beta-metilbutirato.
WO2011119868A3 (en) Hyper-spatial methods for modeling biological events
MX2016009306A (es) Reequilibrado inmunologico epicutaneo.
WO2012047951A3 (en) Human lung stem cells and uses thereof
NZ602380A (en) Peptides for vaccine against birch allergy
PL2892556T3 (pl) Kompozycje i sposoby odnoszące się do leczenia chorób
MX363507B (es) Metodos para administrar óxido nítrico a la sangre arterial o arterializada.
SG195127A1 (en) Methods of treating or preventing neurological diseases
MX2011008179A (es) Peptidos para vacuna.
MX2015012548A (es) Metodos para estimular la maduracion de pulmones e intestinos infantiles.